Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal
non‐Hodgkin lymphoma (NHL) that is confined to the brain, eyes, spinal cord, or …

Importance Spin, the inaccurate reporting of randomized clinical trials (RCTs) with results
that are not statistically significant for the primary end point, distorts interpretation of results …

The article offers guidelines for the diagnosis and management of primary central nervous
system diffuse large B-cell lymphoma. It informs on symptoms associated with the disease …

Formalin‐fixed, paraffin‐embedded (FFPE), biobanked tissue samples offer an invaluable
resource for clinical and biomarker research. Here, we developed a pressure cycling …

Primary central nervous system (CNS) lymphomas represent a subgroup of malignancies
with specific characteristics, an aggressive course, and unsatisfactory outcome in contrast …

Primary central nervous system (CNS) lymphoma is an aggressive brain tumor sensitive to
chemotherapy and radiotherapy. Its incidence has increased in the elderly, and they account …

Purpose In the randomized G-PCNSL-SG-1 trial, the addition of whole brain radiotherapy
(45 Gy) to high-dose methotrexate (HD-MTX)-based chemotherapy (early WBRT arm) did …

Simple Summary High-dose methotrexate (HDMTX) is the backbone of induction therapy for
primary central nervous system lymphoma (PCNSL). There are numerous different protocols …

Simple Summary Primary central nervous system lymphoma is a rare disease with limited
therapeutic options. A more profound understanding of the molecular mechanisms that …

Primary central nervous system lymphoma (PCNSL) is an aggressive variant of extranodal
non-Hodgkin lymphoma (NHL) arising within the brain, leptomeninges, eyes, or spinal cord …